D. Betbeder

发表

Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.

Wei Feng, Jiang Chang, W. Feng, 2009, International journal of pharmaceutics.

Airway delivery of peptides and proteins using nanoparticles.

D. Betbeder, C. Dombu, 2013, Biomaterials.

Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells

R. Matran, Maya Kroubi, D. Betbeder, 2010, Nanotechnology.

Drug delivery systems in the treatment of African trypanosomiasis infections

H. Karembé, Maya Kroubi, D. Betbeder, 2011, Expert opinion on drug delivery.

Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.

A. Paillard, Jiang Chang, Y. Jallouli, 2007, International journal of pharmaceutics.

Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis

H. Karembé, S. Daulouède, P. Vincendeau, 2010, Nanotechnology.

Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells

J. Benoit, M. Morille, C. Passirani, 2011, Pharmaceutical Research.

HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis.

C. Locht, A. Debrie, D. Raze, 2014, Vaccine.

Development and validation of a reversed‐phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers

P. Chavatte, D. Betbeder, E. Lipka, 2017, Electrophoresis.

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.

W. Jiskoot, E. Mastrobattista, J. Heldens, 2008, Vaccine.

Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection.

D. Betbeder, F. Dahmani, T. N'Guyen, 2015, Biomaterials.

Enhancement of Protective Efficacy following Intranasal Immunization with Vaccine Plus a Nontoxic LTK63 Mutant Delivered with Nanoparticles

M. Giuliani, R. Rappuoli, B. Baudner, 2002, Infection and Immunity.

Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro.

A. Alcover, J. Davignon, D. Betbeder, 1996, Vaccine.

Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties

M. Howsam, D. Betbeder, E. Lipka, 2015, International journal of nanomedicine.

Residence time and uptake of porous and cationic maltodextrin‐based nanoparticles in the nasal mucosa: Comparison with anionic and cationic nanoparticles

D. Betbeder, I. Dimier-Poisson, M. Lê, 2018, International journal of pharmaceutics.

Versatile enzymatic diacid ester synthesis of butyl α-D-glucopyranoside

P. Monsan, D. Betbeder, F. Paul, 1993 .

A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens.

P. Perrin, D. Betbeder, S. Morgeaux, 1996, Vaccine.

Characterization of a benzyl-phenoxy-ethanamine binding protein in Trypanosoma equiperdum and the possible relation between binding affinity and trypanocidal activity.

J. Périé, M. Poirot, J. Faye, 1993, Molecular and biochemical parasitology.

Production of homogeneous basic fibroblast growth factor by specific enzymatic hydrolysis of larger microheterogeneous molecular forms.

G. Cauet, P. Monsan, G. Nitti, 1991, Journal of biotechnology.

Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells

L. Dubuquoy, D. Betbeder, R. Carpentier, 2022, International journal of pharmaceutics: X.

Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells.

D. Betbeder, C. Dombu, R. Carpentier, 2012, Biomaterials.

Biovector™ Nanoparticles Improve Antinociceptive Efficacy of Nasal Morphine

B. Francés, D. Betbeder, J. Zajac, 2000, Pharmaceutical Research.

Targeting Drug Delivery to the Brain via Transferrin Anchored Nanoparticles

Jiang Chang, D. Betbeder, 2012 .

Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep

N. Moiré, D. Betbeder, I. Dimier-Poisson, 2020, Frontiers in Immunology.

Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.

P. Moingeon, L. Mascarell, S. Tourdot, 2013, Vaccine.

Prevention of influenza virus infection and transmission by intranasal administration of a porous maltodextrin nanoparticle-formulated vaccine.

P. Staeheli, V. Bernasconi, N. Lycke, 2020, International journal of pharmaceutics.

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

P. Moingeon, L. Mascarell, D. Betbeder, 2007, The Journal of allergy and clinical immunology.

Starch-based NP act as antigen delivery systems without immunomodulating effect

L. Dubuquoy, D. Betbeder, F. Fasquelle, 2022, PloS one.

Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses.

S. Fournel, Neila Chekkat, B. Frisch, 2017, International journal of pharmaceutics.

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

S. Fournel, B. Frisch, E. Werkmeister, 2012, International journal of pharmaceutics.

The effect of alpha-galactosylceramide on the activation of Natural Killer T lymphocytes.

F. Trottein, D. Betbeder, 2009, Vaccine.

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.

A. Louise, P. Moingeon, L. Mascarell, 2008, The Journal of allergy and clinical immunology.

Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors.

P. Perrin, C. Leclerc, O. Merten, 1994, Vaccine.

Anti-trypanosomal compounds. I. In vivo and in vitro activity of inhibitors of glycolysis in trypanosomes

T. Baltz, D. Betbeder, A. Klaébé, 1990 .

A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration.

D. Betbeder, F. Triebel, S. El mir, 2001, European journal of cancer.

Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules.

B. Bertin, L. Dubuquoy, V. Gnemmi, 2019, Journal of hepatology.

Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles.

J. Tocanne, D. Betbeder, M. Major, 1997, Biochimica et biophysica acta.

Proofs of the Structure of Lipid Coated Nanoparticles (SMBV™) Used as Drug Carriers

Ignacio De Miguel, Laurent Imbertie, Valerie Rieumajou, 2000, Pharmaceutical Research.

The Enzymatic Synthesis of Imidazole Deoxynucleosides: 1-β-D-2′-Deoxyribofuranosyl-5-aminoiinidazole-4-carboxamide and 1-β-D-2′-Deoxyribofuranosylbenzimidazole

D. Betbeder, D. Hutchinson, 1990 .

The stereoselective enzymatic synthesis of 9-beta-D-2'-deoxyribofuranosyl 1-deazapurine.

D. Betbeder, D. Hutchinson, A. O. Richards, 1989, Nucleic acids research.

Enzymatic Sywmesis of Dideoxyribonucleosides

D. Betbeder, C. M. Heath, D. Hutchinson, 1991 .

Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma

Jiang Chang, J. Sheng, Xubo Yuan, 2010, Journal of materials science. Materials in medicine.

NEW METHODS TO DETERMINE THE EXTENT OF REACTION OF EPICHLOROHYDRIN WITH MALTODEXTRINS

D. Betbeder, V. Rieumajou, I. Miguel, 1999 .

Improved Synthesis of Sodium Alkyl-Glucopyranuronates

P. Monsan, D. Betbeder, F. Paul, 1993 .

Preparation and characterization of novel chitosan and β-cyclodextrin polymer sponges for wound dressing applications.

N. Tabary, F. Cazaux, V. Gaucher, 2017, Carbohydrate polymers.

Regiospecific enzymic acylation of butyl α-d-glucopyranoside

J. Périé, P. Monsan, D. Betbeder, 1993 .

Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis

F. Nesslany, D. Betbeder, A. Platel, 2016, Journal of applied toxicology : JAT.

Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis

S. Cojean, P. Loiseau, D. Betbeder, 2021, PLoS neglected tropical diseases.

Separation of dipalmitoyl phosphatidyl choline, cholesterol and their degradation products by high-performance liquid chromatography on a perfluorinated stationary bonded phase

D. Betbeder, I. Miguel, Annick Roueche, 1999 .

The Enzymatic Synthesis and Anti-HIV-1 Activity of 9-β-D-2′,3′-Dideoxynucleosides of N(6)-Substituted Purines

D. Betbeder, D. Kinchington, D. Hutchinson, 1990 .

Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.

C. Vaccher, D. Betbeder, D. Le Broc-Ryckewaert, 2013, International journal of pharmaceutics.

Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice.

P. Pisella, D. Betbeder, I. Dimier-Poisson, 2017, Future microbiology.

Positively-Charged, Porous, Polysaccharide Nanoparticles Loaded with Anionic Molecules Behave as ‘Stealth’ Cationic Nanocarriers

J. Benoit, C. Passirani, A. Paillard, 2009, Pharmaceutical Research.

Chapter 1 - Drug delivery to the brain using colloidal carriers.

A. Barras, Jiang Chang, Y. Jallouli, 2009, Progress in brain research.

Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles

D. Betbeder, I. Dimier-Poisson, F. Fasquelle, 2018, International journal of pharmaceutics: X.

Porous Maltodextrin-Based Nanoparticles: A Safe Delivery System for Nasal Vaccines

F. Nesslany, D. Betbeder, A. Platel, 2018, Journal of Nanomaterials.

Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles

D. Betbeder, I. Dimier-Poisson, R. Carpentier, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections

X. Saelens, P. Staeheli, A. Omokanye, 2018, Front. Immunol..

Chimeric Protein , IE 1-pp 65 Donors by Using a Soluble Recombinant Cytomegalovirus-Seropositive Blood Blood Mononuclear Cells of Human T Cells from Peripheral + and CD 8 + CD 4 Ex Vivo Stimulation and Expansion of both

P. Rohrlich, J. Davignon, D. Betbeder, 2001 .

IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy.

P. Rohrlich, J. Davignon, D. Betbeder, 2002, Cytotherapy.

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses.

K. Melber, Roger Kravtzoff, Didier Betbeder, 2002, Vaccine.

STRUCTURAL CHARACTERIZATION OF ORGANIZED SYSTEMS OF POLYSACCHARIDES AND PHOSPHOLIPIDS BY LIGHT SCATTERING SPECTROSCOPY AND ELECTRON MICROSCOPY

M. Prieto, N. Santos, M. Castanho, 1997 .

Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.

L. Fenart, R. Cecchelli, B. Dehouck, 1999, The Journal of pharmacology and experimental therapeutics.

Study of serum interaction with a cationic nanoparticle: Implications for in vitro endocytosis, cytotoxicity and genotoxicity.

F. Nesslany, F. Le Curieux, D. Marzin, 2012, International journal of pharmaceutics.

The Shape, Dimension and Organisation of Maltodextrins Gel Fragments with and without Associated Phospholipids

M. Prieto, N. Santos, M. Castanho, 1997 .

Formulation and characterization of polyphenol-loaded lipid nanocapsules.

A. Barras, P. Melnyk, D. Betbeder, 2009, International journal of pharmaceutics.

STRUCTURAL CHARACTERIZATION (SHAPE AND DIMENSIONS) AND STABILITY OF POLYSACCHARIDE/LIPID NANOPARTICLES

M. Prieto, N. Santos, M. Castanho, 1997 .

Nasal nanovaccines.

D. Betbeder, R. Carpentier, B. Bernocchi, 2017, International journal of pharmaceutics.

Importance of the Phospholipid Core for Mucin Hydrogel Penetration and Mucosal Cell Uptake of Maltodextrin Nanoparticles.

D. Betbeder, J. Desseyn, F. Fasquelle, 2020, ACS applied bio materials.

Effects of γ- and Hydroxypropyl-γ-cyclodextrins on the Transport of Doxorubicin across an in Vitro Model of Blood-Brain Barrier

L. Fenart, R. Cecchelli, H. Bricout, 2004, Journal of Pharmacology and Experimental Therapeutics.

Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells

J. Benoit, M. Morille, C. Passirani, 2012, Pharmaceutical Research.

Effective immuno-therapeutic treatment of Canine Leishmaniasis

R. Ramos, D. Betbeder, F. Fasquelle, 2023, PLoS neglected tropical diseases.

Vaccination of squirrel monkeys (Saimiri spp.) with nanoparticle based-Toxoplasma gondii antigens: new hope for captive susceptible species.

D. Aubert, I. Villena, N. Moiré, 2023, International journal for parasitology.

Fluosol 43 intravascular persistence in mice measured by 19F nmr

R. Martino, D. Betbeder, G. Francois, 1984, The Journal of pharmacy and pharmacology.

Vectorization by nanoparticles decreases the overall toxicity of airborne pollutants

F. Nesslany, D. Betbeder, A. Platel, 2017, PloS one.

Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis

F. Nesslany, D. Betbeder, A. Platel, 2016, Journal of applied toxicology : JAT.